MYD88 and colitis: It was shown that azoxymethane (AOM)-DSS-induced colitis triggered up-regulation of Iqgap2 expression in MyD88-/- colons and not in the similarly treated WT controls [49] (S1 Table), suggesting that MyD88 or its downstream effectors may negatively regulate IQGAP2 expression.